Capital World Investors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-272,000
Closed -$28.6M 552
2019
Q2
$28.6M Hold
272,000
0.01% 397
2019
Q1
$28.7M Hold
272,000
0.01% 394
2018
Q4
$22.8M Hold
272,000
0.01% 424
2018
Q3
$27.7M Hold
272,000
0.01% 437
2018
Q2
$22M Hold
272,000
﹤0.01% 458
2018
Q1
$20M Hold
272,000
﹤0.01% 432
2017
Q4
$19.2M Sell
272,000
-68,000
-20% -$4.91M ﹤0.01% 436
2017
Q3
$21.2M Sell
340,000
-625,000
-65% -$37M ﹤0.01% 425
2017
Q2
$55.4M Sell
965,000
-393,000
-29% -$23.1M 0.01% 337
2017
Q1
$82.6M Sell
1,358,000
-285,454
-17% -$16.1M 0.02% 303
2016
Q4
$90.2M Hold
1,643,454
0.02% 286
2016
Q3
$75.8M Hold
1,643,454
0.02% 300
2016
Q2
$55.9M Buy
+1,643,454
New +$51.3M 0.02% 322

Other funds holding NGVT

Capital World Investors's NGVT Position: Q3 2019 in Review

Capital World Investors sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 272,000 shares — an estimated $28.6M sold.

Capital World Investors first reported a position in NGVT in Q2 2016 and held it in 13 quarters. The position peaked at $90.2M in Q4 2016. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Capital World Investors reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • Capital World Investors sold 272,000 Ingevity shares in Q3 2019, an estimated $28.6M.
  • Capital World Investors first reported a position in Ingevity in Q2 2016 and held it in 13 quarters.
  • Capital World Investors's Ingevity position peaked at $90.2M in Q4 2016.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Capital World Investors's 13F filing for Q3 2019, filed 14 Nov 2019.